Key result
Hypocaloric diets modestly reduce depressive symptoms vs no specific advice in adults with elevated cardiometabolic risk.
Why the study?
The comparative effectiveness of different dietary interventions for improving depression and anxiety symptoms in adults with elevated cardiometabolic risk remains unclear.
Do dietary interventions improve depressive and anxiety symptoms in adults with elevated cardiometabolic risk?
Meta-Analysis (n=3,002)
Do dietary interventions improve depressive and anxiety symptoms in adults with elevated cardiometabolic risk?
In adults with elevated cardiometabolic risk, hypocaloric diets may offer favorable effects on depressive and anxiety symptoms compared to other dietary patterns, though the certainty of evidence is low to moderate.
Hypocaloric diets may be prioritized for depressive symptom relief in cardiometabolic-risk adults; extends comparative ranking of dietary patterns from RCT network meta-analysis.
Depression and anxiety are highly prevalent among individuals with elevated cardiometabolic risk and are associated with adverse clinical outcomes. Although dietary interventions are increasingly recognized as potential adjunctive strategies for improving mental health, their comparative effectiveness remains unclear. This study conducted a network meta-analysis to compare and rank different dietary interventions in this population. We performed a Bayesian network meta-analysis of randomized controlled trials to compare the effects of different dietary interventions on depressive and anxiety symptoms in adults with elevated cardiometabolic risk. Randomized trials evaluating dietary interventions were systematically identified, and both direct and indirect evidence were synthesized. The primary outcomes were changes in depressive and anxiety symptoms. Treatment effects were estimated as standardized mean differences (SMDs) with 95% credible intervals (CrIs). The surface under the cumulative ranking curve was used to rank interventions. Meta-regression analyses were conducted to explore the influence of baseline body mass index (BMI), age, and sex distribution. Fourteen trials involving 3,002 participants were included. Hypocaloric diets showed a greater improvement in depressive symptoms than Mediterranean-style diets (SMD, -0.27; 95% CrI, -0.55 to -0.01; Low certainty of evidence) and low‑carbohydrate diet (SMD, -0.47; 95% CrI, -0.89 to -0.07; Low certainty of evidence). Hypocaloric (SMD, -0.52; 95% CrI, -0.99 to -0.07; Low certainty of evidence), low-fat (SMD, -0.49; 95% CrI, -0.83 to -0.14; Low certainty of evidence), and Mediterranean-style (SMD, -0.48; 95% CrI, -0.89 to -0.04; Low certainty of evidence) diets were associated with greater reductions in anxiety symptoms compared with low‑carbohydrate diets. Meta-regression analyses indicated that each 1-unit increase in BMI was associated with a 0.0363-unit greater reduction in depressive symptom scores (β = -0.0363, P = 0.020). These findings were consistent in participants without preexisting depression or anxiety. In adults with elevated cardiometabolic risk, hypocaloric diets showed relatively favorable effects on depressive symptoms, while hypocaloric and low-fat diets showed favorable effects on anxiety symptoms in some comparisons. However, the certainty of evidence was moderate to low, and most comparisons were supported by limited direct evidence. Further large-scale randomized controlled trials are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a meta-analysis in Elevated cardiometabolic risk (n=3,002). Hypocaloric diet vs. No specific dietary advice was evaluated on Changes in depressive symptoms (SMD -0.31, 95% CI -0.52 to -0.12). Hypocaloric diets significantly reduced depressive symptoms compared with no specific dietary advice (SMD -0.31) in adults with elevated cardiometabolic risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: